Delayed microglial activation associated with the resolution of neuroinflammation in a mouse model of sublethal

Atsuyoshi Shimada1, Makiko Murata1, Sayaka Aoyagi2

  • 1Pathology Research Team, Faculty of Health Sciences, Kyorin University, 5-4-1 Shimorenjaku, Mitaka, Tokyo 181-8612, Japan.

Toxicology Reports
|December 15, 2022
PubMed

Insights

Systemic inflammation triggers astrocyte activation, leading to microglial M2 polarization and neuroinflammation resolution. This study reveals how microglia respond to altered brain environments post-LPS challenge.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Systemic inflammation impacts brain function.
  • Previous work showed choroid plexus macrophages and astrocytes respond to lipopolysaccharide (LPS).
  • The effect of astrocyte-derived cytokines on other brain cells, particularly microglia, was unknown.

Purpose of the Study:

  • To investigate microglial activation in response to astrocyte-induced brain microenvironment changes.
  • To determine the phenotype and role of microglia during systemic inflammation.

Main Methods:

  • Mice were injected with sublethal doses of lipopolysaccharide (LPS).
  • Luminex assays measured hippocampal cytokine levels (CCL11, CXCL10, G-CSF).
  • Immunohistochemistry assessed microglial morphology, and gene expression analysis (RT-PCR) was performed on isolated microglia.

Main Results:

  • Hippocampal CCL11, CXCL10, and G-CSF levels increased at 48 hours post-LPS, returning to baseline by 72 hours.
  • Microglia showed hypertrophy and an M2-like phenotype 48 hours after LPS injection.
  • Isolated microglia expressed higher levels of receptors for CCL11, CXCL10, and G-CSF.

Conclusions:

  • Microglial hypertrophy and M2 polarization follow astrocytic responses in a mouse model of endotoxemia.
  • Activated microglia play a role in resolving neuroinflammation induced by systemic inflammation.

Related Concept Videos